Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Filed by AKIN GUMP STRAUSS HAUER & FELD.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-01 06:26:09 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2026
Income
$120,000.00
Expenses
Not reported
Filing UUID
6d1cc988-0faf-4ce9-8f9a-6881c0eb6cd3
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

CPT · Copyright/Patent/Trademark

Issues related to patent reform legislation. Issues related to H.R. 3160/S. 1553 - The PREVAIL Act.

Literal federal measure citations: H.R. 3160, S. 1553

HCR · Health Issues

Issues related to budget reconciliation; Issues related to Most Favored Nation pricing proposals; Issues related to Senate Democrat member request for information related to drug pricing.

TRD · Trade (domestic/foreign)

Issues related to IP protection; Issues related to market access issues; Issues related to PhRMA 232.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.